Loading...

HSDT HELIUS MEDICAL TECHNOLOGIES INC Expansion Plans 8-K Filing

HLS

HSDT

HELIUS MEDICAL TECHNOLOGIES INC

(HSDT)

2024 8-K

Show Summary

Show Summary

Rights Offerings

Reverse Stock Split

Equity Offerings

Annual Meeting Results

Nasdaq Compliance

Nasdaq Compliance Issue

Warrant Inducement

Medicare Rates Update

PoNS Sale Announcement

Strategic Alternatives

Financial Results

Compliance with Nasdaq List...

Annual Meeting Announcement

Earnings Reports

Public Offering

Financial Results Announcement

Bylaws Amendments

CMS Reimbursement for PoNS ...

Regulation FD Disclosure

Earnings Reports

Earnings Reports

Assignment of UPCs to PoNS ...

Reverse Stock Split

Financial Results Announcement

Sales Agreement with Roth C...

Annual Meeting Results

Results of Operations and F...

Delisting Notice

Financial Results Announcement

Financial Results and Corpo...

External Links:

Helius Medical Technologies is exploring strategic alternatives to maximize stockholder value and has engaged B. Riley Securities as a financial advisor; they also rebutted a pricing determination by CMS for their PoNS Controller, which is set at $2,

AI Assistant

HELIUS MEDICAL TECHNOLOGIES INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.